Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
Ann Oncol
; 35(5): 409-411, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38484973
Full text:
1
Database:
MEDLINE
Main subject:
Neoplasm, Residual
/
Neoadjuvant Therapy
/
Triple Negative Breast Neoplasms
Limits:
Female
/
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2024
Type:
Article
Affiliation country:
Belgium